Cargando…
Genome-Scale CRISPR-Cas9 Transcriptional Activation Screening in Metformin Resistance Related Gene of Prostate Cancer
Metformin is a classic type II diabetes drug which possesses anti-tumor properties for various cancers. However, different cancers do not respond to metformin with the same effectiveness or acquire resistance. Thus, searching for vulnerabilities of metformin-resistant prostate cancer is a promising...
Autores principales: | Chen, Jiahong, Huang, Yaqiang, Tang, Zhenfeng, Li, Maozhang, Ling, Xiaohui, Liao, Jinxian, Zhou, Xiaobo, Fang, Shumin, Zhao, Haibo, Zhong, Weide, Yuan, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870801/ https://www.ncbi.nlm.nih.gov/pubmed/33575255 http://dx.doi.org/10.3389/fcell.2020.616332 |
Ejemplares similares
-
CRISPR/Cas9 in Gastrointestinal Malignancies
por: Jefremow, André, et al.
Publicado: (2021) -
CRISPR Cas9 in Pancreatic Cancer Research
por: Yang, Hai, et al.
Publicado: (2019) -
Opportunities for CRISPR/Cas9 Gene Editing in Retinal Regeneration Research
por: Campbell, Leah J., et al.
Publicado: (2017) -
Breakage of CRISPR/Cas9-Induced Chromosome Bridges in Mitotic Cells
por: Rodriguez-Muñoz, Marina, et al.
Publicado: (2021) -
Application of CRISPR/Cas9 System in Establishing Large Animal Models
por: Lin, Yingqi, et al.
Publicado: (2022)